We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
275 hedge funds and large institutions have $5.04B invested in Acadia Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 105 increasing their positions, 70 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
107% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 29
55% more capital invested
Capital invested by funds: $3.25B → $5.04B (+$1.78B)
50% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 70
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
11% more funds holding
Funds holding: 247 → 275 (+28)
2.69% more ownership
Funds ownership: 95.3% → 97.99% (+2.7%)
10% less call options, than puts
Call options by funds: $29.2M | Put options by funds: $32.5M
Holders
275
Holders Change
+28
Holders Change %
+11.34%
% of All Funds
4.01%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.13%
New
60
Increased
105
Reduced
70
Closed
29
Calls
$29.2M
Puts
$32.5M
Net Calls
-$3.33M
Net Calls Change
+$19.8M
Top Buyers
| 1 |
BlackRock
New York
|
+$33M |
| 2 |
State Street
Boston,
Massachusetts
|
+$29.9M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$22.9M |
| 4 |
Morgan Stanley
New York
|
+$20.7M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$19.3M |
Top Sellers
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$31.5M |
| 2 |
D.E. Shaw & Co
New York
|
-$24.7M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$19.6M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$18.3M |
| 5 |
Millennium Management
New York
|
-$15.5M |
